This federal contract award is for the delivery of the GARDASIL 9 SYRINGE 0.5ML vaccine to the Defense Logistics Agency (DLA), a defense agency. The $3,006.56 firm-fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that larger IDC.
Generated 3/13/25, 9:48 AM